Digital Built around the NHS ward: 5 Norwegian healthtech innovators Norwegian healthtech companies are operating inside NHS trusts – tackling everyday problems that shape care.
Digital How a Norwegian hospital unlocked capacity without adding st... The question for healthcare leaders is less whether AI has a role in surgical planning, and more how to implement it best.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.